| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.23 | 0.2 |